🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

13 recruiting trials

for Lymphodepleting Chemotherapy

Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors NCT06072989Phase 12 sites📍 Shanghai📍 Shanghai Shanghai East Hospital · Tests: B4T2-001 autologous CAR-T A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies NCT06930651Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Dexamethasone, Cyclophosphamide, Fludarabine, Decitabine, TGFBR2 KO CAR27/IL-15 NK cells Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer NCT07589543Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: EB-DUALNK, Cyclophosphamide, Fludarabine Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders NCT06434363Phase 1, Phase 22 sites📍 Houston📍 Houston M.D. Anderson Cancer Center · Tests: Tafasitamab, Fludarabine phosphate, Cyclophosphamide, Tafasitamab and NK cells Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies NCT06383572Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cyclophosphamide, Fludarabine phosphate, Decitabine, Dexamethasone Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances NCT05110742Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Fludarabine Phosphate, Cyclophosphamide, CAR.5/IL15-transduced CB-NK cells AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas NCT06340737Phase 11 site📍 Palo Alto Stanford University · Tests: CD22CART Infusion Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances NCT05092451Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cyclophosphamide, CAR.70/IL15-transduced CB-NK cells, Fludarabine phosphate Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 NCT06083883Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors NCT07589530Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: EB-NK-301, Fludarabine CAR T-cell Therapy in Patients With Renal Dysfunction NCT05909059Phase 21 site📍 Atlanta Northside Hospital, Inc. · Tests: Fludarabine, Cyclophosphamide CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia NCT06847269Phase 21 site📍 Memphis St. Jude Children's Research Hospital · Tests: Fludarabine, Cyclophosphamide, Mesna, CD19-CAR T cell Infusion Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies NCT06699771Phase 13 sites📍 Seoul📍 Seoul📍 Seoul GC Cell Corporation · Tests: GCC2005, Cyclophosphamide, Fludarabine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy